• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES LLC EDWARDS INTUITY ELITE VALVE SYSTEM; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES LLC EDWARDS INTUITY ELITE VALVE SYSTEM; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number 8300AB
Device Problems Perivalvular Leak (1457); Insufficient Information (3190); Activation Failure (3270)
Patient Problems Hemolytic Anemia (2279); Heart Failure/Congestive Heart Failure (4446); Insufficient Information (4580)
Event Date 05/12/2023
Event Type  Injury  
Manufacturer Narrative
H10: additional manufacturer narrative: the investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Event Description
Edwards implant patient registry received information a 25mm 8300ab aortic valve implanted four (4) years, five (5) months, was explanted due to unknown reasons.The explanted device was replaced with a 27mm 3300tfx aortic valve.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional "customer complaint".The information reported may or may not be related to the edwards device.
 
Manufacturer Narrative
H10: additional manufacturer narrative: lot history review: lot history review was performed per (b)(4) and no similar complaints were found for the lot/wo.The complaints found during the lot history review are not related to the investigation of this complaint because the mechanism of failure is different.Engineering evaluation summary: the complaint was confirmed through medical records.Ifu/labeling are adequate.Rmw is adequate.There is no evidence to suggest an edwards/supplier manufacturing defect.A pra is not required because it does not meet the requirements at this time, per (b)(4) capa/scar is not required.Root cause analysis: the subject device was not returned for evaluation as it was discarded by the hospital and no pictures of the device were provided for evaluation.A dhr review was performed, and no relevant non-conformances were identified.Based on the limited information available, the complaint was confirmed, and the most likely cause is procedural factors, including that in the initial procedure the valve was not fully deployed and there was an area of non-apposition to the ventricular wall and therefore the source of the pvl.An edwards defect has not been confirmed.All pertinent information available to edwards lifesciences has been submitted.
 
Event Description
It was learned through edwards implant patient registry and medical record that a 25mm 8300ab aortic valve implanted four (4) years, five (5) months, was explanted due to under deployment of valve skirt causing paravalvular leak.The patient presented worsening hemolytic anemia, nyha 11.The explanted device was replaced with a 27mm 3300tfx aortic valve.Per medical record: the patient underwent redo avr, at time of surgery it was noted the subvalvular skirt of the intuity had not been fully deployed and there was an area of non-apposition to the ventricular wall and therefore the source of the pvl.The post cpb tee demonstrated an excellent valvular replacement, no pvl, no stenosis and no new wall abnormalities.
 
Manufacturer Narrative
H11: corrective data: in the supplemental medwatch# 35018, section h6: 114 - operational problem identified was selected under the investigation findings.However, the section has been corrected and updated to 4248 - usage problem identified based on the additional information obtained from medical record.Engineering evaluation summary has been updated as follows: engineering evaluation summary: the subject device was not returned for evaluation as it was discarded by the hospital and no pictures of the device were provided for evaluation.An operative report was, however, provided for review, confirming the reported partial expansion of the valve frame and describing that further annular debridement was performed prior to implanting the replacement valve.A dhr review was performed, and no relevant non-conformances were identified, and lot history review found no similar incidents.Per technical summary (b)(4), asymmetric frame expansion can occur due to improper seating."asymmetric frame expansion is not considered a failure mode.The shape of the expanded frame is determined by the balloon inflation pressure and by the shape and mechanical characteristics of the valve annulus." based on the limited information available, the complaint was confirmed and likely caused by operational context/procedural factors, including not fully deploying the valve frame at the time of initial implant and potential patient factors of annular calcification.An edwards defect has not been confirmed.All pertinent information available to edwards lifesciences has been submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EDWARDS INTUITY ELITE VALVE SYSTEM
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES LLC
1 edwards way
irvine CA 92614
Manufacturer Contact
saurav singh
1 edwards way
mle fl2- office m2013
irvine, CA 92614
9492506615
MDR Report Key17260898
MDR Text Key318446576
Report Number2015691-2023-14355
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150036
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 08/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/05/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/27/2022
Device Model Number8300AB
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received08/23/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/28/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening; Hospitalization;
Patient Age64 YR
Patient SexMale
-
-